We are happy to share that our CEO, Dr. Taulant Muka, has been listed among the top 1% of the most influential scientists globally, according to the prestigious annual ranking by Elsevier and Stanford. This recognition is based on the impact of both his citations and authorship.
This news not only brings great pride to Epistudia but also reinforces our commitment to working with the best minds in science, ensuring we deliver top-tier education and research. Dr. Muka's impressive academic journey includes training and work at leading institutions such as Erasmus University, Harvard, Cambridge, Stanford, and the University of Bern. His research focuses on evidence synthesis and understanding sex and gender differences in cardiometabolic health.
